These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7814796)

  • 1. Portal pressure after prophylactic sclerotherapy in patients with high-risk varices.
    Toyonaga A; Iwao T; Sumino M; Oho K; Ikegami M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
    J Hepatol; 1994 Oct; 21(4):515-20. PubMed ID: 7814796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration.
    Akahane T; Iwasaki T; Kobayashi N; Tanabe N; Takahashi N; Gama H; Ishii M; Toyota T
    Am J Gastroenterol; 1997 Jun; 92(6):1026-30. PubMed ID: 9177524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive portal venographic pattern in patients with sclerotherapy resistant oesophageal varices.
    Toyonaga A; Iwao T; Sumino M; Takagi K; Oho K; Shigemori H; Tanikawa K
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1110-4. PubMed ID: 9034928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal venous system after endoscopic sclerotherapy of esophageal varices in patients with liver cirrhosis--prospective study with Doppler sonography.
    Szczepanik AB; Proniewski J; Huszcza S
    Hepatogastroenterology; 2005; 52(65):1448-51. PubMed ID: 16201093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic sclerotherapy in cirrhotics--preliminary results of a prospective, controlled, randomized trial.
    Gupta P; Kar P; Chakrovarty A
    Indian J Gastroenterol; 1993 Jan; 12(1):27. PubMed ID: 8330921
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic endoscopic sclerotherapy of esophageal varices in liver cirrhosis--long-term follow-up and final results of a multicenter prospective controlled randomized trial in Vienna.
    Pötzi R; Bauer P; Schöfl R; Reichel W; Kerstan E; Renner F; Gangl A
    Endoscopy; 1993 May; 25(4):287-9. PubMed ID: 8330548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis.
    Strauss E; Ribeiro MF; Albano A; Honain NZ; Maffei RA; Caly WR
    J Gastroenterol Hepatol; 1999 Mar; 14(3):225-30. PubMed ID: 10197490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sclerotherapy for the prevention of bleeding esophageal varices].
    Paquet KJ
    Internist (Berl); 1983 Feb; 24(2):81-4. PubMed ID: 6341290
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there an indication for prophylactic endoscopic paravariceal injection sclerotherapy in patients with liver cirrhosis and portal hypertension?
    Paquet KJ; Koussouris P
    Endoscopy; 1986 May; 18 Suppl 2():32-5. PubMed ID: 3519193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of portosystemic collaterals by SPECT imaging after endoscopic variceal sclerotherapy: usefulness for predicting recurrence.
    Azuma M; Kashiwagi T; Nagasawa M; Ito Y; Naito M; Ishibashi K; Katayama K
    J Nucl Med; 2000 Apr; 41(4):600-4. PubMed ID: 10768559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna.
    Pötzi R; Bauer P; Reichel W; Kerstan E; Renner F; Gangl A
    Gut; 1989 Jun; 30(6):873-9. PubMed ID: 2666282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gastric fundal varices.
    Matsumoto A
    Hepatology; 2008 Jul; 48(1):343-4. PubMed ID: 18506856
    [No Abstract]   [Full Text] [Related]  

  • 13. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma: prospective randomized study.
    Akahoshi T; Tomikawa M; Tsutsumi N; Hashizume M; Maehara Y
    Dig Endosc; 2014 Mar; 26(2):172-7. PubMed ID: 23650913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction.
    Kahn D; Krige JE; Terblanche J; Bornman PC; Robson SC
    Ann Surg; 1994 Jan; 219(1):34-9. PubMed ID: 8297173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic sclerosing of esophageal varices. Results of a prospective randomized 7-year longitudinal study].
    Wördehoff D; Spech HJ
    Dtsch Med Wochenschr; 1987 Jun; 112(24):947-51. PubMed ID: 3496202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of portal pressure with intravascular esophageal variceal pressure (IEVP) directly measured with a flexible indwelling needle.
    Watari A; Miyata K; Kanazawa H; Kobayashi M
    Gastroenterol Jpn; 1993 Oct; 28(5):631-7. PubMed ID: 8224615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic endoscopic variceal sclerotherapy on portal pressure in cirrhotics.
    Korula J; Ralls P
    Gastroenterology; 1991 Sep; 101(3):800-5. PubMed ID: 1860642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
    Piecha F; Paech D; Sollors J; Seitz HK; Rössle M; Rausch V; Mueller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G179-G187. PubMed ID: 29051188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of enalapril treatment and sclerotherapy of esophageal varices on hepatic hemodynamics in portal hypertension.
    Svoboda P; Ochmann J; Kantorová I
    Hepatogastroenterology; 1992 Dec; 39(6):549-52. PubMed ID: 1336475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
    Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
    Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.